Clinical Trial: Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358234) titled 'Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.' on Dec. 23, 2025.

Brief Summary: The purpose of this study is to compare Eosinophilic Esophagitis treatments Eohilia with Dupixent in their effects on diameter and scarring of the esophagus.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Eosinophilic Esophagitis (EoE)

Intervention: DRUG: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

300 mg weekly injection

DRUG: budesonide oral suspension

2mg twice daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mayo Clinic

Information provided by (Resp...